Cargando…
Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines
Somatostatin analogs (SSA) are well-established antisecretory drugs in functionally active neuroendocrine tumors (NET). Two placebo-controlled trials have recently demonstrated significant improvement of progression-free survival under SSA treatment. Furthermore, somatostatin receptor (SSTR) overexp...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897986/ https://www.ncbi.nlm.nih.gov/pubmed/29681888 http://dx.doi.org/10.3389/fendo.2018.00146 |